HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS MAPP BIOPHARMACEUTICAL, INC. $60,500 DEFENSE HEALTH AGENCY (DHA) DEFENSE HEALTH AGENCY (DHA) — 325413 In-Vitro Diagnostic Substance Manufacturing 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS Sep 16, 2025 Sep 19, 2025 Feb 25, 2026
ANTIBODY & ANTIGEN SUPPLY MAPP BIOPHARMACEUTICAL, INC. $110,500 DEFENSE HEALTH AGENCY (DHA) DEFENSE HEALTH AGENCY (DHA) — 325413 In-Vitro Diagnostic Substance Manufacturing 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS Jun 5, 2025 Jun 6, 2025 Dec 4, 2025
DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS MAPP BIOPHARMACEUTICAL, INC. $38,243,034 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AJ11 GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH Mar 19, 2024 Mar 20, 2024 Dec 31, 2032
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION. MAPP BIOPHARMACEUTICAL, INC. $299,045,139 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT Sep 28, 2022 Sep 28, 2022 Jul 31, 2036
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES MAPP BIOPHARMACEUTICAL, INC. $906,651,398 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541714 Research and Development in Biotechnology (except Nanobiotechnology) 6505 DRUGS AND BIOLOGICALS Sep 27, 2022 Sep 30, 2022 Sep 29, 2032
BASE YEAR FOR MACV CONTRACT GENERATES MACV IGG2 MAPP BIOPHARMACEUTICAL, INC. $1,192,803 DEFENSE HEALTH AGENCY (DHA) DEFENSE HEALTH AGENCY (DHA) — 541380 Testing Laboratories and Services AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT Sep 24, 2021 Sep 30, 2021 Mar 1, 2025
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE MAPP BIOPHARMACEUTICAL, INC. $16,413,163 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541714 Research and Development in Biotechnology (except Nanobiotechnology) 6505 DRUGS AND BIOLOGICALS Sep 28, 2020 Sep 30, 2020 Jun 30, 2026
STTR PHASE II MAPP BIOPHARMACEUTICAL, INC. $1,499,004 DEPT OF THE ARMY DEPT OF THE ARMY — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AD25 Aug 5, 2020 Jul 28, 2020 Feb 28, 2023
STTR PHASE I MAPP BIOPHARMACEUTICAL, INC. $149,999 DEPT OF THE ARMY DEPT OF THE ARMY — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Sep 27, 2018 Sep 21, 2018 Jun 30, 2019
IGF::OT::IGF MAPP BIOPHARMACEUTICAL, INC. $62,511,942 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT Sep 25, 2018 Sep 25, 2018 Dec 31, 2024
IGF::OT::IGF MAPP BIOPHARMACEUTICAL, INC. $293,443,870 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541711 AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH Sep 28, 2017 Sep 30, 2017 Aug 31, 2021
IGF::OT::IGF MAPP BIOPHARMACEUTICAL, INC. $7,486,451 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541711 AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT Sep 13, 2017 Sep 13, 2017 Jun 30, 2022
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP MAPP BIOPHARMACEUTICAL, INC. $28,870,288 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541720 Research and Development in the Social Sciences and Humanities AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Jun 24, 2016 Jun 27, 2016 Dec 31, 2027
IGF::OT::IGF SBIR PHASE II - MONTHLY STATUS REPORTS MAPP BIOPHARMACEUTICAL, INC. $999,928 DEPT OF THE ARMY DEPT OF THE ARMY — 541712 AJ11 GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH May 12, 2016 May 27, 2016 Mar 15, 2019
IGF::CL::IGF FOR OTHER FUNCTIONS ADVANCED DEVELOPMENT OF ZMAPP, AN EBOLA VIRUS CANDIDATE MEDICAL COUNTERMEASURE MAPP BIOPHARMACEUTICAL, INC. $52,369,282 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541711 AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Sep 2, 2014 Sep 2, 2014 Aug 31, 2020
SBIR PHASE I MAPP BIOPHARMACEUTICAL, INC. $149,877 DEPT OF THE ARMY DEPT OF THE ARMY — 541712 AJ11 GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH Jun 13, 2014 Jun 11, 2014 May 19, 2016
IGF::OT::IGF BASE PERIOD - PSC: AN12 RESEARCH AND DEVELOPMENT SERVICES MAPP BIOPHARMACEUTICAL, INC. $6,173,324 DEFENSE CONTRACT MANAGEMENT AGENCY (DCMA) DEFENSE THREAT REDUCTION AGENCY (DTRA) — 541711 AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Jun 10, 2014 Jun 10, 2014 Aug 31, 2017
BASE YEAR MAPP BIOPHARMACEUTICAL, INC. $12,566,308 DEFENSE THREAT REDUCTION AGENCY (DTRA) DEFENSE THREAT REDUCTION AGENCY (DTRA) — 541711 AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Feb 19, 2013 Feb 15, 2013 Aug 31, 2017
IGG FRACTIONATION OF NHP SERUM MAPP BIOPHARMACEUTICAL, INC. $234,260 DEPT OF THE ARMY DEPT OF THE ARMY — 541711 R499 SUPPORT- PROFESSIONAL: OTHER Jun 1, 2012 Jun 8, 2012 Dec 7, 2015